STAT+: Using AI to design small molecule drugs is tough. Here are five companies trying to crack the code

These five startups are trying to get AI models to design small-molecule drugs at a better hit rate than traditional experiments.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks